Skip to content
CRI Logo
  • About
    • Impact
    • History
    • Team
    • Careers
    • Blog
    • Media Room
  • What is Immunotherapy?
    • Immunotherapy Basics
    • Treatment Types
    • Cancer Types
    • Side Effects
  • Patient Support
    • Patient Resources
    • Clinical Trials
    • Immunotherapy Stories
    • Connect with ImmunoAdvocates
  • Grants & Research Programs
    • Apply for Grants
    • Clinical Accelerator
    • Data Programs
    • CRI Funded Scientists
  • Get Involved
    • Ways to Give
    • Fundraise
    • Events
    • Partnership
    • Contact
Donate

Immune to Cancer: The CRI Blog

  • Curious About Cancer Care? These Are Breakthroughs and Trends in Immunotherapy

    Cancer immunotherapy is the most innovative and forward-thinking form of cancer treatment available to patients today. Important,…
    January 18, 2024| Max Mallet
  • Four CRI Scientists Elected to AACR 2024 Class of Fellows 

    The American Association for Cancer Research (AACR) has announced its new class of Fellows of the AACR…
    January 16, 2024| Max Mallet
  • Patient Immunotherapy Summit: Hot Topics and Trends in Cancer Immunotherapy

    January 9, 2024| Max Mallet
  • Patient Immunotherapy Summit: Lung Cancer Brief

    Thomas Urban Marron, MD, PhD, Icahn School of Medicine at Mount Sinai and CRI Clinical Innovator, is…
    January 9, 2024| Max Mallet
  • Patient Immunotherapy Summit: I’m the Answer to Cancer™ Barry’s Patient Story

    Barry Nelson is a lung cancer survivor residing in Boston, Massachusetts. A CRI Immuno-Advocate, Barry graciously shares…
    January 9, 2024| Max Mallet
  • Patient Immunotherapy Summit: Breast Cancer Brief

    While one in eight women in the U.S. will develop breast cancer in their lifetime, the good…
    January 9, 2024| Max Mallet
  • Patient Immunotherapy Summit: I’m the Answer to Cancer™ Jeff’s Patient Story

    Since immunotherapy has become a more mainstream form of cancer treatment, more people are choosing to use…
    January 8, 2024| Max Mallet
  • Patient Immunotherapy Summit: Ovarian Cancer Brief

    It is important for the public to be aware of the scope of ovarian cancer, as over…
    January 8, 2024| Max Mallet
  • Patient Immunotherapy Summit: Pancreatic Cancer Brief

    Pancreatic cancer is one of the most difficult cancers to treat with immunotherapy and is the third-leading…
    January 8, 2024| Max Mallet
Previous Page
1 … 17 18 19 20 21 … 98
Next Page
Father and son

Join CRI in Shaping the Future of Immunotherapy

Support the pioneering work of CRI in advancing immunotherapy.

See ways to give

Uniting for a World
Immune to Cancer

Stay Up To Date

Get Patient Stories & Research Updates


Donate By Mail

Cancer Research Institute
29 Broadway, Floor 4
New York, NY 10006-3111

Quick Links

  • Our Annual Impact
  • Blog
  • Careers
  • Contact Us
  • Donate

Trusted & Top-Rated charity

Charity Navigator
Candid Platinum Transparency 2026
Charity Watch Top Rated
BBB Accredited Business

connect with Us

LinkedIn icon
Facebook Icon
X icon
Instagram icon
YouTube icon

The Cancer Research Institute is a 501(c)(3) charitable organization. Our Federal Tax ID Number is 13-1837442.

©2026 Cancer Research Institute

*Immunotherapy results may vary from patient to patient.

  • Accessibility Statement
  • Privacy Policy
  • Terms & Conditions
Trigger Donate Modal